Reducing skin redness in traumatized and problem skin

When testing the Bacocalmine used in our Problem Skin Range, a test was performed to determine the reduction of inflammation achieved with the Bacocalmine™ ingredient.

Test information

10 subjects were exposed to 5% SDS (sodium dodecyl sulfate) using occlusive patches.

SDS-induced inflammation takes the form of redness of the skin and the possible appearance of micro-spots. Objective quantification being impossible just by visual reading, variations in micro-capillary blood flow was measured by Doppler-Laser.

Both forearm sites were sensitive to irritation caused by 5% SDS, with an inflammatory type reaction leading to increased blood flow in skin capillaries and with visual evidence of typical redness.

Measurements revealed a 126% increase in micro-cutaneous flow on placebo while it was only 102% on BACOCALMINE™. These photos below shows the marked anti-inflammatory action of -24% in comparison with placebo.

In certain individuals, the effect persisted sufficiently long for a marked visual difference between the placebo site and BACOCALMINE™ site to be seen 24 hours after the final application, as illustrated by the photos above.

• For more clinical information on how this test was done, please click here.

With this in mind it is easy to understand why we included Bacocalmine™ in our Problem Skin Range, since it effectively helps to reduce the skin redness so often experienced with problem skin and acne skin.